|
Court Rules Genes Can Be Patented: Biotech Victory, Prometheus Blow
In a victory for the biotechnology industry, the U.S. Court of Appeals for the Federal Circuit ruled 2–1 to reaffirm its earlier ruling that Myriad Genetics can patent genes related to its breast and ovarian cancer screening system.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives